USPTO Examiner PENG BO JOSEPH - Art Unit 3797

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19314663CONTOUR-ADAPTIVE ULTRASOUND SYSTEM FOR FAT TISSUE TREATMENTAugust 2025January 2026Allow500NoNo
18951431PHYSIOLOGY SENSING INTRALUMINAL DEVICE WITH INDEX FOR SPECTRAL FLOW ASSESSMENT, AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSNovember 2024February 2026Allow1510NoNo
18948054Marker Materials and Forms for Magnetic Marker Localization (MML)November 2024March 2026Allow1600NoNo
18884964Quantitative Magnetic Resonance Imaging of the VasculatureSeptember 2024January 2026Allow1610NoNo
18827011MONITORING AND ANALYSIS OF INVASIVE AND NON-INVASIVE ELECTROPHYSIOLOGICAL SIGNALSSeptember 2024December 2025Allow1520NoNo
18826479ULTRASONIC TREATMENT DEVICESeptember 2024November 2025Allow1511NoNo
18821043SURFACING INSIGHTS INTO LEFT AND RIGHT VENTRICULAR DYSFUNCTION THROUGH DEEP LEARNINGAugust 2024January 2026Allow1701NoNo
18816014ULTRASOUND IMAGING SYSTEM HAVING DIGITAL ULTRASONIC IMAGING DEVICESAugust 2024July 2025Allow1100NoNo
18838731FETAL HEART RATE MONITORINGAugust 2024December 2025Allow1610YesNo
18790986APPARATUS AND METHOD FOR AUTOMATIC ULTRASOUND SEGMENTATION FOR VISUALIZATION AND MEASUREMENTJuly 2024December 2025Allow1710NoNo
18727262Method And Device For Determining Intracranial Pressure Of A PatientJuly 2024February 2026Allow2001NoNo
18669847SYSTEM AND METHODS FOR A MEASUREMENT TOOL FOR MEDICAL IMAGINGMay 2024January 2026Abandon2001NoNo
18709702IMPROVEMENTS IN ULTRASOUND BASED BLOOD FLOW VELOCITY MEASUREMENTSMay 2024October 2025Allow1700NoNo
187083523D ULTRASOUND IMAGING WITH FOV ADAPTATIONMay 2024November 2025Allow1820NoNo
18697683Device for performing ultrasonic examinations and pressure measurementsApril 2024January 2026Allow2210NoNo
18697502LEAKAGE-PREVENTING COUPLING STRUCTURE OF TRANSDUCER ARRAY OF HIGH-INTENSITY FOCUSED ULTRASOUND GENERATOR, AND TRANSDUCER ARRAYApril 2024January 2026Allow2110NoNo
18697507ELECTRODE STRUCTURE USING TRANSDUCER HOLDER OF TRANSDUCER ARRAY OF HIGH-INTENSITY FOCUSED ULTRASOUND GENERATION DEVICE, AND TRANSDUCER ARRAYApril 2024January 2026Allow2110NoNo
18593440Ultrasound Methods and Systems for Measuring Physiological PropertiesMarch 2024December 2025Allow2210YesNo
18543420ENERGY BASED FAT REDUCTIONDecember 2023February 2026Abandon2630NoNo
18541633BEAMFORMING METHOD AND SYSTEMDecember 2023January 2026Abandon2610NoNo
18288238CIRCULATORY SYSTEM ASSESSMENTOctober 2023January 2026Allow2720NoNo
18461394MULTISPECTRAL PHOTOACOUSTIC DEVICESSeptember 2023September 2025Allow2420NoNo
18461423PHOTOACOUSTIC SENSOR WITH LIGHT-STEERING SYSTEMSeptember 2023February 2026Allow3021NoNo
18214233SLEEP AID APPARATUS AND CONTROL THEREOFJune 2023March 2026Allow3300NoNo
18258452SYSTEM FOR APPLICATION OF ALTERNATING MAGNETIC FIELDS TO REDUCE INFECTIONJune 2023March 2026Allow3300NoNo
18136542MOBILE ALGORITHM-BASED VASCULAR HEALTH EVALUATION PROCESSESApril 2023December 2025Allow3211NoNo
18186124PHASE SEGMENTATION OF A PERCUTANEOUS MEDICAL PROCEDUREMarch 2023February 2026Allow3521NoNo
18245382CHAMBER ASSEMBLY FOR PREMATURE FETUSMarch 2023January 2026Allow3400NoNo
18168839Surgical Navigation System with Distributed Patient Reference TrackingFebruary 2023January 2026Allow3611NoNo
18082405SYSTEMS, DEVICES, AND METHODS FOR COREGISTRATION OF INTRAVASCULAR DATA TO ENHANCED STENT DEPLOYMENT X-RAY IMAGESDecember 2022January 2026Allow3720NoNo
18063236SURGICAL DEVICE FOR USE IN SPINAL OR MUSCULOSKELETAL SURGERY OR IN SIMULATED SURGERY AND METHOD OF USING THE SAMEDecember 2022February 2026Allow3921NoNo
17920654OCT CATHETER WITH LOW REFRACTIVE INDEX OPTICAL MATERIALOctober 2022November 2025Allow3720NoNo
17909139DIFFERENTIAL PREDICTION OF ABERRATION CORRECTIONS FOR ULTRASOUND THERAPYSeptember 2022July 2025Allow3411YesNo
17393524METHOD, DEVICE, AND SYSTEM FOR DETERMINING ABNORMALITY IN MYOCARDIUM REGIONAugust 2021February 2026Allow5570YesNo
14858770System And Method For Optimal Catheter Selection For Individual Patient AnatomySeptember 2015April 2019Allow4331NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner PENG, BO JOSEPH - Prosecution Strategy Guide

Executive Summary

Examiner PENG, BO JOSEPH works in Art Unit 3797 and has examined 2 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 55 months.

Allowance Patterns

Examiner PENG, BO JOSEPH's allowance rate of 100.0% places them in the 100% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PENG, BO JOSEPH receive 5.00 office actions before reaching final disposition. This places the examiner in the 99% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PENG, BO JOSEPH is 55 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by PENG, BO JOSEPH. This interview benefit is in the 17% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.